» Articles » PMID: 34594327

Characterization of Organ-Specific Regulatory B Cells Using Single-Cell RNA Sequencing

Overview
Journal Front Immunol
Date 2021 Oct 1
PMID 34594327
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Regulatory B cells (Breg) are considered as immunosuppressive cells. Different subsets of Breg cells have been identified both in human beings and in mice. However, there is a lack of unique markers to identify Breg cells, and the heterogeneity of Breg cells in different organs needs to be further illuminated. In this study, we performed high-throughput single-cell RNA sequencing (scRNA-seq) and single-cell B-cell receptor sequencing (scBCR-seq) of B cells from the murine spleen, liver, mesenteric lymph nodes, bone marrow, and peritoneal cavity to better define the phenotype of these cells. Breg cells were identified based on the expression of immunosuppressive genes and IL-10-producing B (B10) cell-related genes, to define B10 and non-B10 subsets in Breg cells based on the score of the B10 gene signatures. Moreover, we characterized 19 common genes significantly expressed in Breg cells, including , , , , and , and further analyzed the transcription factor activity in defined Breg cells. Last, a BCR analysis was used to determine the clonally expanded clusters and the relationship of Breg cells across different organs. We demonstrated that may potentially modulate the function of Breg cells as a transcription factor and that seven organ-specific subsets of Breg cells are found. Depending on gene expression and functional modules, non-B10 Breg cells exhibited activated the TGF-β pathway, thus suggesting that non-B10 Breg cells have specific immunosuppressive properties different from conventional B10 cells. In conclusion, our work provides new insights into Breg cells and illustrates their transcriptional profiles and BCR repertoire in different organs under physiological conditions.

Citing Articles

Revealing the role of regulatory b cells in cancer: development, function and treatment significance.

Ye R, Li S, Li Y, Shi K, Li L Cancer Immunol Immunother. 2025; 74(4):125.

PMID: 39998678 PMC: 11861783. DOI: 10.1007/s00262-025-03973-w.


Butyrate: a bridge between intestinal flora and rheumatoid arthritis.

Cao Y, Chen J, Xiao J, Hong Y, Xu K, Zhu Y Front Immunol. 2024; 15:1475529.

PMID: 39478858 PMC: 11521846. DOI: 10.3389/fimmu.2024.1475529.


The role of immune cells settled in the bone marrow on adult hematopoietic stem cells.

Xu H, Li Y, Gao Y Cell Mol Life Sci. 2024; 81(1):420.

PMID: 39367881 PMC: 11456083. DOI: 10.1007/s00018-024-05445-3.


The current understanding of the phenotypic and functional properties of human regulatory B cells (Bregs).

Ahsan N, Lourenco S, Psyllou D, Long A, Shankar S, Bashford-Rogers R Oxf Open Immunol. 2024; 5(1):iqae012.

PMID: 39346706 PMC: 11427547. DOI: 10.1093/oxfimm/iqae012.


Regulatory B Cells Expressing Granzyme B from Tolerant Renal Transplant Patients: Highly Differentiated B Cells with a Unique Pathway with a Specific Regulatory Profile and Strong Interactions with Immune System Cells.

Sailliet N, Dupuy A, Brinas F, Renaudin K, Colas L, Kerleau C Cells. 2024; 13(15.

PMID: 39120317 PMC: 11311295. DOI: 10.3390/cells13151287.


References
1.
Mauri C, Menon M . Human regulatory B cells in health and disease: therapeutic potential. J Clin Invest. 2017; 127(3):772-779. PMC: 5330739. DOI: 10.1172/JCI85113. View

2.
Matsushita T, Yanaba K, Bouaziz J, Fujimoto M, Tedder T . Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008; 118(10):3420-30. PMC: 2542851. DOI: 10.1172/JCI36030. View

3.
Davis R . FCRL regulation in innate-like B cells. Ann N Y Acad Sci. 2015; 1362:110-6. PMC: 4690519. DOI: 10.1111/nyas.12771. View

4.
Blair P, Norena L, Flores-Borja F, Rawlings D, Isenberg D, Ehrenstein M . CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity. 2010; 32(1):129-40. DOI: 10.1016/j.immuni.2009.11.009. View

5.
Fontenot J, Gavin M, Rudensky A . Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003; 4(4):330-6. DOI: 10.1038/ni904. View